Table I.
DRD2 (n) | |||
---|---|---|---|
Variable | Low | High | P-value |
Age | 0.578 | ||
≥65 years | 26 | 18 | |
<65 years | 26 | 14 | |
Gender | 0.466 | ||
Female | 11 | 9 | |
Male | 41 | 23 | |
Tumor volume | 0.623 | ||
≥35 cm3 | 23 | 16 | |
<35 cm3 | 27 | 15 | |
Tumor differentiation | 0.163 | ||
I, II, II–III | 18 | 16 | |
III | 34 | 16 | |
Metastasis | 0.299 | ||
Yes | 1 | 2 | |
No | 51 | 30 | |
Node positive | 0.587 | ||
≥5 | 25 | 13 | |
<5 | 27 | 18 | |
TNM stage | 0.311 | ||
1A-2B | 22 | 10 | |
3A-4 | 30 | 22 |
DRD2, dopamine receptor D2; TNM, tumor-node-metastasis.